These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15540204)

  • 1. Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry.
    Ramström M; Ivonin I; Johansson A; Askmark H; Markides KE; Zubarev R; Håkansson P; Aquilonius SM; Bergquist J
    Proteomics; 2004 Dec; 4(12):4010-8. PubMed ID: 15540204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein identification in cerebrospinal fluid using packed capillary liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.
    Ramström M; Palmblad M; Markides KE; Håkansson P; Bergquist J
    Proteomics; 2003 Feb; 3(2):184-90. PubMed ID: 12601811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-capillary liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry--a powerful tool for peptide and protein identification.
    Ramström M; Palmblad M; Amirkhani A; Tsybin YO; Markides KE; Håkansson P; Bergquist J
    Acta Biochim Pol; 2001; 48(4):1101-4. PubMed ID: 11995972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small peptide CSF fingerprint of amyotrophic lateral sclerosis.
    Lumi R; Petri S; Siwy J; Latosinska A; Raad J; Zürbig P; Skripuletz T; Mischak H; Beige J
    PLoS One; 2024; 19(4):e0302280. PubMed ID: 38687737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry.
    Ramström M; Bergquist J
    FEBS Lett; 2004 Jun; 567(1):92-5. PubMed ID: 15165899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.
    Wuolikainen A; Jonsson P; Ahnlund M; Antti H; Marklund SL; Moritz T; Forsgren L; Andersen PM; Trupp M
    Mol Biosyst; 2016 Apr; 12(4):1287-98. PubMed ID: 26883206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual electrospray ionization source for confident generation of accurate mass tags using liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.
    Nepomuceno AI; Muddiman DC; Bergen HR; Craighead JR; Burke MJ; Caskey PE; Allan JA
    Anal Chem; 2003 Jul; 75(14):3411-8. PubMed ID: 14570191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tryptic peptides from large databases using multiplexed tandem mass spectrometry: simulations and experimental results.
    Masselon C; Pasa-Tolić L; Lee SW; Li L; Anderson GA; Harkewicz R; Smith RD
    Proteomics; 2003 Jul; 3(7):1279-86. PubMed ID: 12872228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.
    Ranganathan S; Nicholl GC; Henry S; Lutka F; Sathanoori R; Lacomis D; Bowser R
    Amyotroph Lateral Scler; 2007 Dec; 8(6):373-9. PubMed ID: 17852009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of tryptic digestion investigated by quantitative fourier transform ion cyclotron resonance mass spectrometry.
    Hagman C; Ramström M; Jansson M; James P; Håkansson P; Bergquist J
    J Proteome Res; 2005; 4(2):394-9. PubMed ID: 15822915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative metabolome analysis of human cerebrospinal fluid by 13C-/12C-isotope dansylation labeling combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.
    Guo K; Bamforth F; Li L
    J Am Soc Mass Spectrom; 2011 Feb; 22(2):339-47. PubMed ID: 21472593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular differentiation of ischemic and valvular heart disease by liquid chromatography/fourier transform ion cyclotron resonance mass spectrometry.
    Baykut D; Grapow M; Bergquist M; Amirkhani A; Ivonin I; Reineke D; Grussenmeyer T; Hakansson P; Zerkowski HR; Baykut G; Bergquist J
    Eur J Med Res; 2006 Jun; 11(6):221-6. PubMed ID: 16820333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.
    Barschke P; Oeckl P; Steinacker P; Ludolph A; Otto M
    Expert Rev Proteomics; 2017 Sep; 14(9):769-777. PubMed ID: 28799854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis.
    Andrés-Benito P; Povedano M; Domínguez R; Marco C; Colomina MJ; López-Pérez Ó; Santana I; Baldeiras I; Martínez-Yelámos S; Zerr I; Llorens F; Fernández-Irigoyen J; Santamaría E; Ferrer I
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchrotron-Based Fourier-Transform Infrared Micro-Spectroscopy of Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients Reveals a Unique Biomolecular Profile.
    Dučić T; Koch JC
    Cells; 2023 May; 12(11):. PubMed ID: 37296572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry.
    Blasco H; Corcia P; Pradat PF; Bocca C; Gordon PH; Veyrat-Durebex C; Mavel S; Nadal-Desbarats L; Moreau C; Devos D; Andres CR; Emond P
    J Proteome Res; 2013 Aug; 12(8):3746-54. PubMed ID: 23859630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
    Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.